26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
作者信息
Cheitlin M D, Douglas P S, Parmley W W
出版信息
J Am Coll Cardiol. 1994 Oct;24(4):874-80. doi: 10.1016/0735-1097(94)90843-5.